US Broker Ratings

Baxter International Inc. (BAX) Stock Analysis: Exploring the 20.7% Upside Potential

Baxter International Inc. (NYSE: BAX), a titan in the healthcare sector, stands at a pivotal juncture with a market capitalization of $12.3 billion. Specializing in medical instruments and supplies, the..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: 29% Potential Upside Beckons Investors

With a market capitalization of $28.88 billion, GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a prominent player in the medical devices industry, operating within the healthcare sector in the..

Ascendis Pharma A/S (ASND) Stock Analysis: Is the 18.6% Upside a Green Light for Investors?

Ascendis Pharma A/S (NASDAQ: ASND), a leading biopharmaceutical company headquartered in Hellerup, Denmark, has caught the attention of investors with its remarkable potential upside of 18.6%. Operating in the dynamic..

Chemed Corp (CHE) Stock Analysis: Robust Revenue Growth and Strategic Positioning in Healthcare

Chemed Corp (CHE), a key player in the healthcare sector, operates prominently within the medical care facilities industry. As of the latest data, the company’s market capitalization stands at $6.74..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating a Healthcare Giant’s Potential Upside

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, continues to be a compelling consideration for investors. With a market capitalization of $355.1 billion, this American pharmaceutical..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Encompass Health Corporation (EHC) Stock Analysis: Potential 21.74% Upside Amid Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC), a major player in the medical care facilities industry, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. With a current market..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 15% Upside Potential

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector with a focus on medical devices, presents an intriguing opportunity for investors. With a robust market capitalization..

Tenet Healthcare Corporation (THC) Stock Analysis: What’s Driving the 8.12% Potential Upside?

Tenet Healthcare Corporation (NYSE: THC) is capturing the attention of investors with a notable 8.12% potential upside, according to the latest analyst ratings. As a key player in the healthcare..

Incyte Corporation (INCY): Investor Outlook on Robust Revenue Growth and Strategic Collaborations

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is currently capturing investor attention with its impressive revenue growth and strategic focus on innovative therapeutics. Headquartered in Wilmington,..

Zoetis Inc. (ZTS)

⚠️ No article content returned.

..

Cardinal Health, Inc. (CAH) Stock Analysis: Insights on a 15.5% Potential Upside and Strong Buy Ratings

Cardinal Health, Inc. (NYSE: CAH) stands out in the healthcare sector with a robust profile as a medical distribution giant. Headquartered in Dublin, Ohio, this company plays a pivotal role..

Revvity, Inc. (RVTY) Stock Analysis: Navigating Growth with a Strategic Focus in Diagnostics

Revvity, Inc. (RVTY), a prominent player in the healthcare sector specializing in diagnostics and research, presents a compelling investment opportunity with its $13.87 billion market capitalization. As the company continues..

Penumbra, Inc. (PEN) Stock Analysis: Navigating Growth with a 13.88% Potential Upside

As investors scour the healthcare sector for promising opportunities, Penumbra, Inc. (NYSE: PEN) stands out with its innovative medical devices and a market cap of $12.52 billion. Operating within the..

Haleon plc (HLN) Stock Analysis: Exploring a 30% Upside Potential in the Healthcare Sector

Haleon plc (NYSE: HLN), a prominent player in the healthcare sector, is garnering attention from investors thanks to its significant 30.51% potential upside. This UK-based company is a major force..

Takeda Pharmaceutical Company L (TAK) Investor Outlook: Analyzing the 23.77% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a prominent player in the healthcare sector, is capturing investor attention with a robust 23.77% potential upside. Headquartered in Chuo, Japan, Takeda is a..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating Growth Potential Amidst a Competitive Biotech Landscape

Exelixis, Inc. (NASDAQ: EXEL) stands as a formidable player in the biotech sector, primarily focusing on developing oncology treatments. With a market capitalization of $13.91 billion, Exelixis is well-positioned in..

West Pharmaceutical Services (WST) Stock Analysis: Robust Growth and a Promising 17% Upside

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, specializes in providing crucial containment and delivery systems for injectable drugs. With its extensive reach across the..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 34.93% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands out as a compelling player in the healthcare sector, specifically in the drug manufacturing niche focusing on specialty and generic pharmaceuticals. Based in San..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 6.20% Dividend Yield Amidst Market Volatility

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, continues to grab investor attention with its robust dividend yield of 6.20%. As a key player in the global pharmaceutical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds